Information Provided By:
Fly News Breaks for February 2, 2017
EW
Feb 2, 2017 | 07:51 EDT
Canaccord analyst Jason Mills said Edwards Lifesciences remains a top large cap pick for 2017 following its Q4 upside report. The analyst sees his estimates as biased to the upside and recommends investors add to positions. Mills noted the company reiterated its 2017 guidance and expects gross margins to bounce back during the year. Mills reiterated his Buy rating and $140 price target on Edwards shares.
News For EW From the Last 2 Days
There are no results for your query EW
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.